Pharma Sector

Index
  • 1m
  • 6m
  • ytd
  • 1y
  • 3y
  • 5y
  • max
Constituents (239 Companies)
Company Name
PE
Market Cap (Cr.)
M.Cap (Cr.)
37.34
4,51,675
85.37
1,86,190
34.27
1,15,523
25.02
1,12,917
18.68
1,03,299
30.88
99,493
48.52
99,117
25.18
93,499
135
67,160
36.51
65,645
29.82
64,326
35.44
57,232
36.48
47,783
40.88
46,399
42.82
45,736
35.16
35,559
75.25
30,775
103
29,768
30.05
22,088
32.24
21,355
28.80
19,159
112
19,072
29.04
18,701
-
17,797
55.60
17,519
23.33
16,175
13.93
15,935
57.50
15,833
53.20
15,817
29.08
15,029
33.79
13,545
64.95
12,926
67.96
12,412
71.69
11,942
40.16
11,716
64.90
11,108
37.79
10,053
27.06
9,657
-
9,415
14.83
9,098
37.39
7,869
22.75
7,365
56.35
7,121
4.04
6,403
689
5,974
38.53
5,935
19.72
5,770
40.54
5,521
35.03
4,922
28.20
4,740
39.27
4,523
57.02
4,188
-
3,849
78.96
3,844
15.11
3,821
19.59
3,746
45.97
3,726
20.60
3,418
32.70
3,349
47.53
2,725
65.02
2,697
-
2,532
170
2,432
54.85
2,404
20.48
2,379
7.21
2,312
15.11
2,057
359
2,022
55.80
2,014
29.02
1,928
50.62
1,825
31.64
1,810
21.81
1,613
33.82
1,538
16.72
1,430
26.38
1,424
32.14
1,410
22.30
1,349
12.92
1,246
22.15
1,234
35.79
1,105
47.24
1,088
28.90
1,069
38.59
964
24.02
960
-
907
35.38
889
20.38
876
26.56
772
17.21
760
33.57
690
44.34
684
22.81
667
43.46
638
166
615
78.13
608
19.89
598
28.83
580
28.45
518
29.59
474
14.12
463
20.46
462
21.23
461
99.71
461
27.50
435
26.24
362
19.67
350
82.30
334
75.90
329
17.06
325
26.79
314
27.79
301
15.03
292
64.72
292
-
289
54.46
286
31.20
282
62.24
260
-
249
-
245
12.34
243
31.64
236
-
222
22.42
217
-
217
11.22
216
40.60
206
65.05
195
11.17
193
39.03
192
15.84
185
13.54
179
660
171
27.53
169
15.29
157
-
154
13.45
153
31.45
147
11.16
145
9.61
144
18.82
140
18.93
136
15.20
136
30.87
135
55.14
134
18.52
133
14.85
130
18.38
127
51.30
122
-
118
-
118
23.12
117
26.54
113
27.30
113
26.28
111
26.82
109
24.28
108
12.23
98
63.91
98
16.75
97
22.43
93
45.22
93
27.02
92
13.03
90
7.60
87
19.58
77
-
76
-
72
20.18
71
-
71
18.04
70
-
69
33.99
66
14.39
61
7.57
57
2.96
52
106
51
15.30
50
-
45
4.99
45
-
44
-
44
-
44
99.65
44
-
43
-
42
6.12
41
17.23
40
-
39
-
39
9.35
38
12.36
38
304
38
-
37
23.35
36
13.23
33
65.00
33
53.41
33
10.10
33
1,097
32
14.81
31
12.13
31
-
31
8.66
30
-
30
-
28
4.45
27
32.11
27
19.95
25
-
24
84.84
24
30.79
22
7.28
20
-
20
27.20
18
104
17
-
16
27.82
15
-
14
-
14
167
14
8.15
13
-
12
-
12
26.22
12
-
12
30.46
12
18.69
12
-
8
-
7
-
7
89.76
7
-
6
-
5
-
4
69.81
4
44.01
4
-
3
-
2
Showing 5 239 of 239 Show More
Market Share

    Select a Metric
    • Gastrointestinal (Nurokind-LC) - Market Share (%)
    • Fermentation Based API Products - Market Share (%)
    • Depression (Placida) - Market Share (%)
    • Birth Control (Unwanted-72) - Market Share (%)
    • Anti Fungal Antibiotics (Terbinaforce) - Market Share (%)
    • Anti-Hypertensives (Amolkind-AT) Market Share (%)
    • Gastro-Intestinal - Market Share (%)
    • Vaccines - Market Share (%)
    • Sex Stimulants - Market Share (%)
    • Pharmaceutical Sector - Market Share (%)
    • Cardiovascular - Market Share (%)
    • Vitamin & Dietary Supplements - Market Share (%)
    • Anti - Diabetes - Market Share (%)
    • Anti-Infectives - Market Share (%)
    Operational Metrics

    Select a Metric
    • Pharma spend as a % of GDP - India (%)
    • Pharma spend as a % of GDP - Korea (%)
    • Pharma spend as a % of GDP - USA (%)
    • Domestic Pharma - Monthly Sales (Crs)
    • Domestic Pharma Price Growth (%)
    • Domestic Pharma Volume Growth (%)
    • Total ANDA's Approved by USFDA

      Select a Metric
      • Fermentation Capacity (KL)
      • No Of Pharmacies (.)
      • Number of ANDA's Approved By USFDA (.)
      • Number of ANDA's Filed in USA (.)
      • Manufacturing Capacity - Metformin (MTPA)
      • No of Pharmacy Outlets - Kolkata (.)
      • Quarterly Sales Volume - Injectables (Nos)
      • Quarterly Sales Volume - Nutraceuticals (Nos)
      • Quarterly Sales Volume - Orals (Nos)
      • Realization / Tonne - Piperazine (Rs/MT)
      • Manufacturing Capacity - Pyridin-3-One (MTPA)
      • Realization / Tonne - Pyridin-3-One (Rs/MT)
      • Domestic Sales Growth - YoY (%)
      • Number of ANDA's Approved (.)
      • Number of ANDA's Filed in Europe
      • Number of ANDA's Approved in Europe
      • Canada DMF fillings (.)
      • US DMF Filings (.)
      • Australia DMF fillings (.)
      • US DMF Approval (.)
      • Europe DMF Filings (.)
      • DMF Filingsby API (.)
      • Total reactor capacity (kL)
      • Global DMFs filed (.)
      • APIs Production Capacity (MTPA)
      • Japan DMF Filings (.)
      • Capacity Utilization - Benzimidazole (%)
      • Realization - Tetralone (Rs/Tonne)
      • Manufacturing Capacity - Omeprazole (MTPA)
      • Capacity Utilization - Esomeprazole (%)
      • Realization - Pantaprazole Sodium (Rs/Tonne)
      • Capacity Utilization - Omeprazole (%)
      • Manufacturing Capacity - Benzimidazole (MTPA)
      • Realization - Chloro Compound (Rs/Tonne)
      • Manufacturing Capacity - Pantaprazole (MTPA)
      • Realization - Op. Sulphide (Rs/Tonne)
      • Realization - Esomeprazole Magnesium (Rs/Tonne)
      • Capacity Utilization - Chloro Compound (%)
      • Capacity Utilization - Pantaprazole (%)
      • Realization - Benzimidazole (Rs/Tonne)
      • Realization - Omeprazole Powder (Rs/Tonne)
      • Manufacturing Capacity - Esomeprazole (MTPA)
      • Manufacturing Capacity - Chloro Compound (MTPA)
      • Realization - Ammonium Sulphate (Rs/Tonne)
      • Manufacturing Capacity - Ibuprofen (MTPA)
      • Capacity Utilization - Pharmaceuticals (%)
      • Number of ANDA's Filed in Canada
      • Number of ANDA's Approved by Canada
      • Number of ANDA's Filed in Australia
      • Number of ANDA's Approved by Australia
      • Number of ANDA's Filed in South Africa
      • Number of ANDA's Approved by South Africa
      • Number of ANDA's Filed in Latam
      • Number of ANDA's Approved by Latam
      • Manufacturing Capacity - Piperazine (MTPA)
      • Manufacturing Capacity - Paracetamol (MTPA)
      • No of Pharmacy Outlets - Hyderabad (.)
      • No of Pharmacy Outlets - Bangalore (.)
      • No of Pharmacy Outlets - Chennai (.)
      Segments

      Select a Metric
      • Therapeutic wise Break-Up - Domestic Pharma (Crs)
      • Dermatology (Crs)
      • Cardiovascular (Crs)
      • Blood Related (Crs)
      • Antineo Plastic (Crs)
      • Anti-Malarial (Crs)
      • Anti - Infectives (Crs)
      • Vaccines (Crs)
      • Stomatological (Crs)
      • Sex Stimulants (Crs)
      • Respiratory (Crs)
      • Pain (Crs)
      • Others (Crs)
      • Ophthalmology (Crs)
      • Neurological (Crs)
      • Gynecology (Crs)
      • Gastro-Intestinal (Crs)
      • Endocrinology (Crs)
      • Urology (Crs)
      • Vitamin & Dietary Supplements (Crs)
      • Anti - Diabetes (Crs)
      • Indian vs MNC - Domestic Share (Crs)
      • Indian (Crs)
      • MNC (Crs)
      Export Import Data

      • 1y
      • 2y
      • 3y
      • 5y
      • 10y
        Select a Metric
        • Pharmaceutical Products (Kgs)
        Ideas Dashboard
        Results
        Timeline
        Watchlist
        Portfolio
        Alerts
        Stock Screener
        Market
        Raw Material